{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:55:47Z","timestamp":1789764947865,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8181463"],"award-info":[{"award-number":["8181463"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Xinghuo Talent Program of Nanjing First Hospital","award":["Xinghuo Talent Program of Nanjing First Hospital"],"award-info":[{"award-number":["Xinghuo Talent Program of Nanjing First Hospital"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The present study aimed to investigate the preliminary safety and efficacy of rheolytic thrombectomy (RT) using an AngioJet Zelante DVT catheter or a Solent Omni catheter for acute proximal deep vein thrombosis (DVT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective review of 40 patients who were treated with an AngioJet RT between January 2019 and January 2021, and then the patients were divided into the ZelanteDVT group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200917) and the Solent group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200923). Data on demographics, clinical characteristics, technical success, clinical success, complications, and early follow-up were analysed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      No significant differences regarding demographics were detected (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u2009.05). The technical success rates were both 100%. The ZelanteDVT group had a shorter duration of RT and a higher primary RT success than the Solent group (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.05), and the percentage of adjunctive catheter-directed thrombolysis (CDT) was 29.4% in the ZelanteDVT group, which was significantly lower than the 73.9% in the Solent group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.010). The clinical success rates for the ZelanteDVT group and Solent group were 100% (17\/17) and 95.7% (22\/23), respectively, and these values were high in the two groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u2009.05). Apart from transient macroscopic haemoglobinuria occurring in all the patients during the first 24\u2009hours post-RT, none of the patients in either group suffered other procedure-related adverse events or major complications. Minor complications included bleeding events in 21.7% (5\/23) of the patients in the Solent group and one (5.9%) patient in the ZelanteDVT group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u2009.05). At 6\u2009months, the frequency of PTS was 5.9% (1\/17) in the ZelanteDVT group and 17.4% (4\/23) in the Solent group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u2009.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both catheters are safe and effective in managing patients with proximal DVT, thus leading to improved clinical outcomes with few complications. The ZelanteDVT catheter was more effective than the Solent catheter in thrombectomy, thus allowing for faster extraction of the DVT with a shorter run time and lower proportions of patients with adjunctive CDT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12959-023-00472-9","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T16:18:41Z","timestamp":1679847521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Rheolytic thrombectomy using an AngioJet ZelanteDVT catheter or a Solent Omni catheter for patients with proximal vein thrombosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Maofeng","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"472_CR1","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/jcm9051439","volume":"9","author":"S Thukral","year":"2020","unstructured":"Thukral S, Vedantham S. Catheter-based therapies and other management strategies for deep vein thrombosis and post-thrombotic syndrome. J Clin Med. 2020;9:1439. https:\/\/doi.org\/10.3390\/jcm9051439.","journal-title":"J Clin Med"},{"key":"472_CR2","doi-asserted-by":"publisher","first-page":"S1051\u20130443(21)0","DOI":"10.1016\/j.jvir.2021.06.001","volume":"11","author":"S Vedantham","year":"2021","unstructured":"Vedantham S, Salter A, Lancia S, Lewis L, Thukral S, Kahn SR. Clinical outcomes of a pharmacomechanical catheter-directed venous thrombolysis strategy that included rheolytic thrombectomy in a multicenter randomized trial. J Vasc Interv Radiol. 2021;11:S1051\u20130443(21)01150\u20137. https:\/\/doi.org\/10.1016\/j.jvir.2021.06.001.","journal-title":"J Vasc Interv Radiol"},{"issue":"23","key":"472_CR3","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa1615066","volume":"377","author":"S Vedantham","year":"2017","unstructured":"Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377(23):2240\u201352. https:\/\/doi.org\/10.1056\/NEJMoa1615066.","journal-title":"N Engl J Med"},{"issue":"2","key":"472_CR4","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/S2352-3026(15)00248-3","volume":"3","author":"Y Haig","year":"2016","unstructured":"Haig Y, Enden T, Gr\u00f8tta O, Kl\u00f8w NE, Slagsvold CE, Ghanima W, et al. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT):5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol. 2016;3(2):e64\u201371. https:\/\/doi.org\/10.1016\/S2352-3026(15)00248-3 Epub 2016 Jan 6.","journal-title":"Lancet Haematol"},{"key":"472_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jvir.2015.01.036","volume":"26","author":"MJ Garcia","year":"2015","unstructured":"Garcia MJ, Lookstein R, Malhotra R, Amin A, Blitz LR, Leung DA, et al. Endovascular management of deep vein thrombosis with rheolytic thrombectomy: final report of the prospective multicenter PEARL (peripheral use of AngioJet Rheolytic Thrombectomy with a variety of catheter lengths) registry. J Vasc Interv Radiol. 2015;26:777\u201385. https:\/\/doi.org\/10.1016\/j.jvir.2015.01.036 quiz 786. Epub 2015 Mar 29.","journal-title":"J Vasc Interv Radiol"},{"key":"472_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1024\/0301-1526\/a000666","volume":"47","author":"JF Dopheide","year":"2018","unstructured":"Dopheide JF, Sebastian T, Engelberger RP, Haine A, Kucher N. Early clinical outcomes of a novel rheolytic directional thrombectomy technique for patients with iliofemoral deep vein thrombosis. Vasa. 2018;47:56\u201362. https:\/\/doi.org\/10.1024\/0301-1526\/a000666 Epub 2017 Oct 5.","journal-title":"Vasa"},{"key":"472_CR7","doi-asserted-by":"publisher","first-page":"S2213-333X(21)0","DOI":"10.1016\/j.jvsv.2021.01.007","volume":"1","author":"Q Ni","year":"2021","unstructured":"Ni Q, Long J, Guo X, Yang S, Meng X, Zhang L, et al. Clinical efficacy of one-stage thrombus removal via contralateral femoral and ipsilateral tibial venous access for pharmacomechanical thrombectomy in entire-limb acute deep vein thrombosis: a retrospective cohort study. J Vasc Surg Venous Lymphat Disord. 2021;1:S2213-333X(21)00066\u20134. https:\/\/doi.org\/10.1016\/j.jvsv.2021.01.007.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"472_CR8","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.3892\/etm.2019.7938","volume":"18","author":"M Gong","year":"2019","unstructured":"Gong M, Zhao B, He X, Gu J, Chen G. Feasibility of low-dose infusion of alteplase for unsuccessful thrombolysis with urokinase in deep venous thrombosis. Exp Ther Med. 2019;18:3667\u201374. https:\/\/doi.org\/10.3892\/etm.2019.7938 Epub 2019 Aug 26.","journal-title":"Exp Ther Med"},{"key":"472_CR9","doi-asserted-by":"publisher","unstructured":"Kakkos SK, Gohel M, Baekgaard N, Bauersachs R, Bellmunt-Montoya S, Black SA, Ten Cate-Hoek AJ, Elalamy I, Enzmann FK, Geroulakos G, Gotts\u00e4ter A, Hunt BJ, Mansilha A, Nicolaides AN, Sandset PM, Stansby G, Esvs Guidelines Committee, de Borst GJ, Bastos Gon\u00e7alves F, Chakf\u00e9 N, Hinchliffe R, Kolh P, Koncar I, Lindholt JS, Tulamo R, Twine CP, Vermassen F, Wanhainen A, Document Reviewers, De Maeseneer MG, Comerota AJ, Gloviczki P, Kruip MJHA, Monreal M, Prandoni P, Vega de Ceniga M. Editor\u2019s Choice-European Society for Vascular Surgery (ESVS) 2021 Clinical practice guidelines on the management of venous thrombosis. Eur J Vasc Endovasc Surg 2021;61:9\u201382. https:\/\/doi.org\/10.1016\/j.ejvs.2020.09.023. Epub 2020 Dec 15.","DOI":"10.1016\/j.ejvs.2020.09.023"},{"key":"472_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1148\/radiology.211.1.r99ap4739","volume":"211","author":"MW Mewissen","year":"1999","unstructured":"Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39\u201349. https:\/\/doi.org\/10.1148\/radiology.211.1.r99ap4739 Erratum in: Radiology 1999 Dec;213(3): 930.","journal-title":"Radiology"},{"issue":"7 Suppl","key":"472_CR11","doi-asserted-by":"publisher","first-page":"S227","DOI":"10.1016\/j.jvir.2009.04.016","volume":"20","author":"S Vedantham","year":"2009","unstructured":"Vedantham S, Thorpe PE, Cardella JF, Grassi CJ, Patel NH, Ferral H, et al. Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol. 2009;20(7 Suppl):S227\u201339. https:\/\/doi.org\/10.1016\/j.jvir.2009.04.016 PMID: 19560003.","journal-title":"J Vasc Interv Radiol"},{"key":"472_CR12","first-page":"158a","volume":"24","author":"S Villalta","year":"1994","unstructured":"Villalta S, Bagatella P, Piccioli A, Lensing A, Prins M, Prandoni P. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome. Haemostasis. 1994;24:158a.","journal-title":"Haemostasis"},{"issue":"4","key":"472_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.crad.2015.11.016","volume":"71","author":"SH Kwon","year":"2016","unstructured":"Kwon SH, Ahn SE, Shin JS, Youn HC, Kim JH, Oh JH. A phantom model study to identify the most effective manual aspiration thrombectomy for acute deep-vein thrombosis of the lower extremity. Clin Radiol. 2016;71(4):321\u20137. https:\/\/doi.org\/10.1016\/j.crad.2015.11.016 Epub 2016 Jan 9.","journal-title":"Clin Radiol"},{"issue":"143","key":"472_CR14","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.120.049096","volume":"23","author":"W Li","year":"2021","unstructured":"Li W, Kessinger CW, Orii M, Lee H, Wang L, Weinberg I, et al. Time-restricted salutary effects of blood flow restoration on venous thrombosis and vein wall injury in mouse and human subjects. Circulation. 2021;23(143):1224\u201338. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.049096 Epub 2021 Jan 15.","journal-title":"Circulation"},{"key":"472_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.avsg.2015.10.034","volume":"33","author":"SH Lee","year":"2016","unstructured":"Lee SH, Kim HK, Hwang JK, Kim SD, Park SC, Kim JI, et al. Efficacy of retrievable inferior vena cava filter placement in the prevention of pulmonary embolism during catheter-directed thrombectomy for proximal lower-extremity deep vein thrombosis. Ann Vasc Surg. 2016;33:181\u20136. https:\/\/doi.org\/10.1016\/j.avsg.2015.10.034.","journal-title":"Ann Vasc Surg"},{"key":"472_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.crad.2009.01.002","volume":"64","author":"SH Kwon","year":"2009","unstructured":"Kwon SH, Oh JH, Seo TS, Ahn HJ, Park HC. Percutaneous aspiration thrombectomy for the treatment of acute lower extremity deep vein thrombosis: is thrombolysis needed? Clin Radiol. 2009;64:484\u201390. https:\/\/doi.org\/10.1016\/j.crad.2009.01.002 Epub 2009 Mar 18. PMID: 19348843.","journal-title":"Clin Radiol"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-023-00472-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-023-00472-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-023-00472-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T16:21:21Z","timestamp":1679847681000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-023-00472-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["472"],"URL":"https:\/\/doi.org\/10.1186\/s12959-023-00472-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1073588\/v1","asserted-by":"object"}]},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"assertion":[{"value":"15 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the institutional review board (IRB) of the Nanjing First Hospital, Nanjing Medical University (Nanjing, China). In addition, the study was performed in accordance with the Declaration of Helsinki and the Ethical Guidelines for Clinical Studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The content of the manuscript is original, and it has not been published or accepted for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}